Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct 31;140(43):14028-14032.
doi: 10.1021/jacs.8b07709. Epub 2018 Oct 12.

X-ray Crystallographic Structure of a Teixobactin Derivative Reveals Amyloid-like Assembly

Affiliations

X-ray Crystallographic Structure of a Teixobactin Derivative Reveals Amyloid-like Assembly

Hyunjun Yang et al. J Am Chem Soc. .

Abstract

This paper describes the X-ray crystallographic structure of a derivative of the antibiotic teixobactin and shows that its supramolecular assembly through the formation of antiparallel β-sheets creates binding sites for oxyanions. An active derivative of teixobactin containing lysine in place of allo-enduracididine assembles to form amyloid-like fibrils, which are observed through a thioflavin T fluorescence assay and by transmission electron microscopy. A homologue, bearing an N-methyl substituent, to attenuate fibril formation, and an iodine atom, to facilitate X-ray crystallographic phase determination, crystallizes as double helices of β-sheets that bind sulfate anions. β-Sheet dimers are key subunits of these assemblies, with the N-terminal methylammonium group of one monomer and the C-terminal macrocycle of the other monomer binding each anion. These observations suggest a working model for the mechanism of action of teixobactin, in which the antibiotic assembles and the assemblies bind lipid II and related bacterial cell wall precursors on the surface of Gram-positive bacteria.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Teixobactin (1), Lys10-teixobactin (2), and N-Me-d-PheI1,N-Me-d-Gln4Lys10-teixobactin (3).
Figure 2.
Figure 2.
(A) ThT fluorescence assay of Lys10-teixobactin (2, four replicate runs with 120 μM peptide in PBS buffer at pH 7.4). (B) TEM images of the fibrils formed by Lys10-teixobactin (2).
Figure 3.
Figure 3.
X-ray crystallographic structure of a representative dimer of N-Me-d-PheI1,N-Me-d-Gln4,Lys10-teixobactin (3). (A) Top view. (B) Side view.
Figure 4.
Figure 4.
β-Sheet fibril formed by N-Me-d-PheI1,N-Me-d-Gln4Lys10-teixobactin (3). (A) Top view. (B) Bottom view with hydrophobic side chains shown as spheres.
Figure 5.
Figure 5.
Double helix of β-sheet fibrils formed by N-Me-d-PheI1,N-Me-d-Gln4,Lys10-teixobactin (3). Sulfate anions are shown as spheres.
Figure 6.
Figure 6.
Crystallographically based molecular model of an extended double helix of β-sheet fibrils formed by teixobactin analogue 2 and observed by TEM (Figure 2).

References

    1. Ling LL; Schneider T; Peoples AJ; Spoering AL; Engels I; Conlon BP; Mueller A; Schäberle TF; Hughes DE; Epstein S; Jones M; Lazarides L; Steadman VA; Cohen DR; Felix CR; Fetterman KA; Millett WP; Nitti AG; Zullo AM; Chen C; Lewis K A new antibiotic kills pathogens without detectable resistance. Nature 2015, 517, 455–459. - PMC - PubMed
    1. Homma T; Nuxoll A; Gandt AB; Ebner P; Engels I; Schneider T; Götz F; Lewis K; Conlon BP Dual Targeting of Cell Wall Precursors by Teixobactin Leads to Cell Lysis. Antimicrob. Agents Chemother. 2016, 60, 6510–6517. - PMC - PubMed
    1. Zong Y; Sun X; Gao H; Meyer KJ; Lewis K; Rao Y Developing Equipotent Teixobactin Analogues against Drug-Resistant Bacteria and Discovering a Hydrophobic Interaction between Lipid II and Teixobactin. J. Med. Chem. 2018, 61, 3409–3421. - PubMed
    1. Jin K; Sam IH; Po KHL; Lin D; Ghazvini Zadeh EH; Chen S; Yuan Y; Li X Total synthesis of teixobactin. Nat. Commun. 2016, 7, 12394. - PMC - PubMed
    1. Parmar A; Lakshminarayanan R; Iyer A; Mayandi V; Leng Goh ET; Lloyd DG; Chalasani MLS; Verma NK; Prior SH; Beuerman RW; Madder A; Taylor EJ; Singh I Design and Syntheses of Highly Potent Teixobactin Analogues against Staphylococcus aureus, Methicillin-Resistant Staphylococcus aureus (MRSA), and Vancomycin-Resistant Enterococci (VRE) in Vitro and in Vivo. J. Med. Chem. 2018, 61, 2009–2017. - PubMed

Publication types